Precision Medicine, CRISPR, and Genome Engineering Moving from Association to Biology and Therapeutics /

This book presents descriptive overviews of gene editing strategies across multiple species while also offering in-depth insight on complex cases of application in the field of tissue engineering and regenerative medicine.  Chapters feature contributions from leaders in stem cell therapy and biology...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Tsang, Stephen H. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Σειρά:Advances in Experimental Medicine and Biology, 1016
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03518nam a22005535i 4500
001 978-3-319-63904-8
003 DE-He213
005 20171112184635.0
007 cr nn 008mamaa
008 171112s2017 gw | s |||| 0|eng d
020 |a 9783319639048  |9 978-3-319-63904-8 
024 7 |a 10.1007/978-3-319-63904-8  |2 doi 
040 |d GrThAP 
050 4 |a R857.T55 
072 7 |a PSF  |2 bicssc 
072 7 |a SCI049000  |2 bisacsh 
082 0 4 |a 612.028  |2 23 
082 0 4 |a 571.538  |2 23 
245 1 0 |a Precision Medicine, CRISPR, and Genome Engineering  |h [electronic resource] :  |b Moving from Association to Biology and Therapeutics /  |c edited by Stephen H. Tsang. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a IX, 178 p. 19 illus., 15 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1016 
505 0 |a Part 1. Introduction to the CRISPR Revolution.- 1. Viral Vectors, Engineered Cells and the CRISPR Revolution -- 2.  Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing -- Part 2. CRISPR in Model Systems --  3. From Reductionism to Holism: Toward a More Complete View of Development through Genome Engineering -- 4. Genome Engineering in Mice -- 5. Genome Editing to Study Ca2+ Homeostasis in Zebrafish Cone Photoreceptors -- 6. From Prokaryotic Immune Systems to Plant Genome Editing Tools -- 7. Part 3. The Future of CRISPR -- 7. Using High-throughput Gene Editing to Identify Therapeutic Targets in the Noncoding Genome -- 8. CRISPR in the Retina: Evaluation of Future Potential -- 9. The Future of CRISPR Applications in the Lab, the Clinic and Society. 
520 |a This book presents descriptive overviews of gene editing strategies across multiple species while also offering in-depth insight on complex cases of application in the field of tissue engineering and regenerative medicine.  Chapters feature contributions from leaders in stem cell therapy and biology, providing a comprehensive view of the application of gene therapy in numerous fields with an emphasis on ophthalmology, stem cells, and agriculture. The book also highlights recent major technological advances, including ZFN, TALEN, and CRISPR. Precision Medicine, CRISPR, and Genome Engineering is part of the highly successful Advances in Experimental Medicine and Biology series. It is an indispensable resource for researchers and students in genetics as well as clinicians. . 
650 0 |a Life sciences. 
650 0 |a Human genetics. 
650 0 |a Ophthalmology. 
650 0 |a Agriculture. 
650 0 |a Stem cells. 
650 0 |a Regenerative medicine. 
650 0 |a Tissue engineering. 
650 1 4 |a Life Sciences. 
650 2 4 |a Regenerative Medicine/Tissue Engineering. 
650 2 4 |a Stem Cells. 
650 2 4 |a Ophthalmology. 
650 2 4 |a Human Genetics. 
650 2 4 |a Agriculture. 
700 1 |a Tsang, Stephen H.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319639031 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1016 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-63904-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)